Affiliation:
1. University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
2. Cincinnati VAMC, Cincinnati, Ohio, USA
3. Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA
4. Department of Chemistry, University of Cincinnati, Cincinnati, Ohio, USA
Abstract
ABSTRACT
Fungi in the genus
Pneumocystis
live in the lungs of mammals, where they can cause a fatal pneumonia (PCP [
P
neumo
c
ystis
p
neumonia]) in hosts with compromised immune systems. The absence of a continuous
in vitro
culture system for any species of
Pneumocystis
has led to limited understanding of these fungi, especially for the discovery of new therapies. We recently reported that
Pneumocystis carinii
,
Pneumocystis murina
, and most significantly,
Pneumocystis jirovecii
lack both enzymes necessary for
myo-
inositol biosynthesis but contain genes with homologies to fungal
myo
-inositol transporters. Since
myo
-inositol is essential for eukaryotic viability, the primary transporter, ITR1, was functionally and structurally characterized in
P. carinii
. The predicted structure of
P. carinii
ITR1 (PcITR1) contained 12 transmembrane alpha-helices with intracellular C and N termini, consistent with other inositol transporters. The apparent
K
m
was 0.94 ± 0.08 (mean ± standard deviation), suggesting that
myo-
inositol transport in
P. carinii
is likely through a low-affinity, highly selective transport system, as no other sugars or inositol stereoisomers were significant competitive inhibitors. Glucose transport was shown to use a different transport system. The
myo
-inositol transport was distinct from mammalian transporters, as it was not sodium dependent and was cytochalasin B resistant. Inositol transport in these fungi offers an attractive new drug target because of the reliance of the fungi on its transport, clear differences between the mammalian and fungal transporters, and the ability of the host to both synthesize and transport this critical nutrient, predicting low toxicity of potential inhibitors to the fungal transporter.
IMPORTANCE
myo
-Inositol is a sugarlike nutrient that is essential for life in most organisms. Humans and microbes alike can obtain it by making it, which involves only 2 enzymes, by taking it from the environment by a transport process, or by recycling it from other cellular constituents. Inspection of the genomes of the pathogenic fungi of the genus
Pneumocystis
showed that these pneumonia-causing parasites could not make
myo
-inositol, as they lacked the 2 enzymes. Instead, we found evidence of inositol transporters, which would import the sugar from the lungs where the fungi reside. In the present report, we characterized the transport of
myo
-inositol in the fungus and found that the transporter was highly selective for
myo
-inositol and did not transport any other molecules. The transport was distinct from that in mammalian cells, and since mammals can both make and transport
myo
-inositol, while
Pneumocystis
fungi must transport it, this process offers a potential new drug target.
Publisher
American Society for Microbiology
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献